NCT06463262View on ClinicalTrials.gov

Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2031

Conditions
Chordoma of SpineChordoma of Skull BaseChordoma of Sacrum
Interventions
DIAGNOSTIC_TEST

ctDNA

the effects of neoadjuvant RT, in the form of either proton therapy or SBRT, on the ctDNA

Trial Locations (1)

212887

RECRUITING

Johns Hopkins Hospital, Baltimore

Sponsors
All Listed Sponsors
collaborator

Canon Medical Systems, USA

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT06463262 - Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma | Biotech Hunter | Biotech Hunter